(10S)-Lorlatinib Impurity PurCert

(10S)-Lorlatinib Impurity, PurCert

PurCert

Synonym: (R)-2(6)-amino-5(5)-fluoro-1(1),4,7-trimethyl-6-oxo-1(1)H-3-oxa-7-aza-2(3,5)-pyridina-1(4,3)-pyrazola-5(1,2)-benzenacyclooctaphane-1(5)-carbonitrile

Linear Formula: C₂₁H₁₉FN₆O₂

Molecular Weight: 406.41 g/mol

CAS Number: 1454846-35-5

Properties

Assay Purity	>=98%
M pt.	184-187°C
Density	1.42 ± 0.1 g/cm3
Form	Solid

Safety Information

Hazard Statement(s)	H302
Precautionary Statement	P280-P305+P351+P338
GHS Pictogram
Signal word	Warning
Storage Temp.	-20 °C

Description

Application

(10S)-Lorlatinib is applied in pharmaceutical research laboratories for analytical method development impurity profiling stability studies and quality assurance of lorlatinib formulations.

Purpose

The purpose of (10S)-Lorlatinib is primarily to serve as a reference standard impurity marker or research compound during the development synthesis and quality control of lorlatinib drug products. (This use is typical for stereoisomeric forms in pharm

General Description

(10S)-Lorlatinib is a stereoisomer of lorlatinib a kinase inhibitor structurally related to the active pharmaceutical ingredient used in targeted cancer therapy.

Documents


SDS
COA
Specification
Bulk quote order form